Trifecta Signals

← Stocks · DRMA page

Dermata Therapeutics, Inc. (DRMA)

Price chart & company basics · Trifecta Signals

$0.76-$0.09 (-10.89%)Close · Thu, Nov 5, 2026

Price refreshes every trading day after the close.

In the scan since Jan 2022
DRMA closes
-76.0% 1Y · Range $0.66 – $3.22
$1$2$3 Nov ’25Jan ’26Mar ’26May ’26Jul ’26Sep ’26Nov ’26

Daily closes · through the most recent close

Price history from Jan 2018 · Signal tracking began Jan 2022

The Trifecta List

DRMA didn’t make the Trifecta List

Dermata has never had a Trifecta signal in the record — not an Early signal, not a confirmed one — since the record began in January 2022. It is scanned after every trading day’s close along with the full US-listed universe; so far it has never met the conditions.

That’s the whole record for this stock: the chart and the basics above, and nothing to grade.

The list is the public track record: every stock that has signaled, logged, confirmed, and graded.

Dermata Therapeutics is a listed company whose shares trade under the DRMA ticker.

Over the past year the shares have traded between $0.66 and $3.22, and the latest close sits near the bottom of that range. From low to high, that range spans about 386%. Price history on this page reaches back to August 2021.

DRMA closed Thursday, November 5 at $0.76, down 10.9% on the day. Over the past week, the shares have traded in a range between about $0.75 and $0.86.

Download the DRMA report (PDF)Free edition — public summary · Data as of Nov 4, 2026